Sociedad Andaluza de Enfermedades Infecciosas   Report issue

Academic/Hospital Phase 4
Founded: Seville Spain (1993)

Organization Overview

First Clinical Trial
1994
NCT00402454
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 4)

Fibrosis (Phase 3)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

HIV Infections (Phase 4)

Infections (Phase 4)

Liver Cirrhosis (Phase 3)

Tuberculosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 8